MyFinsight
Home
Blog
About
Cash and cash
equivalents
$15,260K
(211.94%↑ Y/Y)
Marketable securities
$4,828K
(-84.13%↓ Y/Y)
Prepaid expenses and
other current assets
$2,167K
(-53.96%↓ Y/Y)
Total current assets
$22,255K
(-44.38%↓ Y/Y)
Property and equipment,
net
$283K
(-93.22%↓ Y/Y)
Other assets
$82K
(-85.23%↓ Y/Y)
Total assets
$22,620K
(-52.57%↓ Y/Y)
Total liabilities and
stockholders' equity
$22,620K
(-52.57%↓ Y/Y)
Total stockholders'
equity
$12,149K
(-59.02%↓ Y/Y)
Total liabilities
$10,471K
(-34.73%↓ Y/Y)
Accumulated deficit
-$460,668K
(-10.23%↓ Y/Y)
Accumulated other
comprehensive (loss) income
-$3K
(57.14%↑ Y/Y)
Additional paid-in capital
$472,816K
(5.64%↑ Y/Y)
Total current
liabilities
$6,413K
(-40.52%↓ Y/Y)
Lease liabilities,
long term
$3,603K
(-22.78%↓ Y/Y)
Other long-term
liabilities
$455K
(-23.66%↓ Y/Y)
Common stock, par value
of 0.001 per share...
$4K
(100.00%↑ Y/Y)
Accrued liabilities and
other liabilities
$3,835K
(-53.44%↓ Y/Y)
Accounts payable
$2,578K
(1.34%↑ Y/Y)
Back
Back
Balance Sheet
NextCure, Inc. (NXTC)
NextCure, Inc. (NXTC)
source: myfinsight.com